| Literature DB >> 26125598 |
Vidhya Ramaswamy1, Adam Monsalve1, Larysa Sautina2, Mark S Segal2,3, Jon Dobson1,4,5, Josephine B Allen1,5.
Abstract
Controlling receptor-mediated processes in cells is paramount in many research areas. The activity of small molecules and growth factors is difficult to control and can lead to off-target effects through the activation of nonspecific receptors as well as binding affinity to nonspecific cell types. In this study, we report the development of a molecular trigger in the form of a divalent nucleic acid aptamer assembly toward vascular endothelial growth factor receptor-2 (VEGFR2). The assembly binds to VEGFR2 and functions as a receptor agonist with targeted receptor binding, promoting receptor phosphorylation, activation of the downstream Akt pathway, upregulation of endothelial nitric oxide synthase, and endothelial cell capillary tube formation. The agonist action we report makes this aptamer construct a promising strategy to control VEGFR2-mediated cell signaling.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26125598 PMCID: PMC4576944 DOI: 10.1089/nat.2014.0519
Source DB: PubMed Journal: Nucleic Acid Ther ISSN: 2159-3337 Impact factor: 5.486